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ABSTRACT 
A simple, sensitive, precise, rapid and reliable HPTLC method for the estimation of ellagic acid in marketed herbal formulation, 
Glucomap tablet was developed. In this method, precoated Silica Gel F254 Plates were used as stationary phase and Toluene: ethyle 
acetate: formic acid: methanol (3:3:8:2 v/v) as mobile phase. Developed chromatogram was scanned at 280 nm, the wavelength of 
maximum absorption for ellagic acid. The aptness of developed HPTLC method for estimation of ellagic acid was established by 
validating it as per the ICH guidelines. The content of ellagic acid in crude drug Terminalia arjuna and polyherbal formulation was 
also studied. The developed method has been successfully applied for the determination of ellagic acid in polyherbal formulation. 
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INTRODUCTION: 
Standardization is necessary to make sure the 
availability of a uniform product in all parts of the 
world
1
. Standardization assures a consistently stronger 
product with guaranteed constituents. WHO collaborates 
and assists health ministries in establishing mechanisms 
for the introduction of traditional plant medicines into 
primary healthcare programs, in assessing safety and 
efficacy, in ensuring adequate supplies, and in the 
quality control of raw and processed materials
2
. 
High-performance thin-layer chromatography (HPTLC) 
is still increasingly finding its way in pharmaceutical 
analysis in some parts of the world. The technique 
achieves for given applications a precision and trueness 
comparable to high performance liquid chromatography 
(HPLC). It also allows simultaneous estimation of 
several samples utilizing only a small quantity of a 
mobile phase, hence minimizing the analysis time and 
cost
3
. On the basis of review of literature a few 
analytical techniques have been reported for the analysis 
of ellagic acid is available for its estimation in 
polyherbal formulations. The main aim of this study was 
to develop and validate an accurate and reproducible 
HPTLC method for estimation of ellagic acid in 
Glucomap tablet as an ingredient. The validation was 
done as per ICH guidelines
4
. 
MATERIALS AND METHODS: 
The fingerprint method for Glucomap tablet was 
developed by high-performance thin layer 
chromatography determination using ellagic acid as a 
standard. The fingerprinting method was developed for 
selected components of GT (Terminalia arjuna), 
laboratory batches (GT-I, GT-II, GT-III) & marketed 
formulation (GTM) via estimation of ellagic acid by 
using following experimental techniques. All chemicals 
and reagents used were of analytical grade and were 
purchased from Hi-Media, India. 
Table 1: Instrumentation and chromatographic 
conditions 
Stationary phase            Precoated Silica Gel F 254 
Plates (Merck) 
Mobile phase                  Toluene: ethyle acetate: formic 
acid: methanol (3: 3: 8: 2 v/v) 
Saturation        40 mins    
Temperature 25 ± 2 ºC  
Development 
chamber   
Glass twin trough development 
chamber 
Applicator CAMAG Linomat IV 
applicator 
Scanner    CAMAG Scanner III Win Cats 
(4.06), Switzerland 
Mode of scanning           Absorption (deuterium)  
Detection wavelength     280 nm 
Scanning Speed             20 mm/s 
Calibration curve of ellagic acid 
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The stock solution of ellagic acid was prepared by 
dissolving 10 mg of ellagic acid in 100 ml of methanol. 
This solution was diluted as needed to prepare different 
concentrations of standard solutions. A stock solution of 
ellagic acid (100 µgmL
−1
) was prepared in methanol. 
Different concentrations of stock solution were prepared 
& spotted on the TLC plate to obtain a 100 - 600 ng 
spot
−1
 of ellagic acid, respectively. The data of peak 
areas plotted against the corresponding concentrations 
were treated by least-square regression analysis method 
validation. 
Method validation  
The method was validated for precision, accuracy, limit 
of detection & limit of quantification, robustness, 
ruggedness & specificity of sample application.  
Precision and accuracy 
Repeatability of the sample application and 
measurement of peak area were carried out using six 
replicates of the same spot (600 ng spot
−1
for ellagic 
acid) was expressed in terms of percent relative standard 
deviation (%RSD). The intra- and inter-day variation for 
the determination of ellagic acid was carried at three 
different concentration levels of 100, 300, 600 ng spot
−1
. 
Limit of detection (LOD) & Limit of quantification 
(LOQ)  
LOD was determined based on the lowest concentration 
detected by instrument in the sample. LOQ was 
determined based on the lowest concentration quantified 
by the instrument in the sample (LOQ = 5 x LOD). In 
order to estimate the limit of detection (LOD) and limit 
of quantification (LOQ), blank methanol was spotted six 
times LOD was considered as 3:1 and LOQ as 10:1. 
LOD and LOQ were experimentally verified by diluting 
the known concentrations of ellagic acid until the 
average responses were approximately 3 or 10 times the 
standard deviation of the responses for six replicate 
determinations. 
Robustness By introducing small changes in the mobile 
phase composition, mobile phase volume, duration of 
mobile phase saturation and activation of pre-washed 
TLC plates with water; the effects on the results were 
examined. Robustness of the method was done in 
triplicate at a concentration level of 600 ng spot−1 for 
ellagic acid and the % R.S.D of peak areas was 
calculated. 
Ruggedness A solution of concentration 600 ng spot
−1
 
was prepared and analyzed on day 0 and after 6, 12, 24, 
48 and 72 h. Data were treated for % RSD to assess 
ruggedness of the method for ellagic acid. 
Specificity The specificity of the method was confirmed 
by analyzing the standard drugs and samples. The spot 
for ellagic acid in the sample was confirmed by 
comparing the Rf values and spectra of the spot with that 
of the standard. The peak purity of the ellagic acid was 
assessed by comparing the spectra at three different 
levels. 
Recovery The recovery was determined by the standard 
addition technique. The pre-analyzed samples were 
spiked with extra 50, 100 and 150 % of the standard 
ellagic acid and the mixtures were reanalyzed by the 
proposed method. The experiment was conducted six 
times. This was done to check for the recovery of the 
ellagic acid at different levels in the formulations.  
RESULTS AND DISCUSSION:  
The method was validated for precision, accuracy, limit 
of detection & limit of quantification, robustness, 
ruggedness & specificity of sample application.  
Precision and accuracy 
The intra- and inter-day variation for the determination 
of ellagic acid was carried at three different 
concentration levels of 100, 300, 600 ng spot
−1
 were 
calculated and depicted in table 1. 
 
Figure 1: HPTLC chromatogram of ellagic acid
 
Table 2: Intra and inter-day precision of HPTLC method 
Amount of ellagic acid Intra -day precision Inter-day precision 
 (ng/spot)  Area ± SD  RSD %  Area ± SD  RSD % 
 100  985.65 ± 0.571  0.058  1148.42 ± 0.387  0.034 
 300  2052.88 ± 0.482  0.023  2275.17 ± 0.474  0.021 
 600  3984.26 ± 0.623  0.016  4159.34 ± 0.691  0.017 
 Mean  0.032   0.024 
 
 
Shrivastava et al                                                                                               Journal of Drug Delivery & Therapeutics. 2017; 7(7):180-182                       
ISSN: 2250-1177                                                                             [182]                                                                             CODEN (USA): JDDTAO 
Limit of detection (LOD) & Limit of quantification 
(LOQ) 
LOD and LOQ were experimentally verified by diluting 
the known concentrations of ellagic acid and found to be 
71.85 and 222.73 respectively (Table 2).  
Table 3: Summary of validation parameters of HPTLC 
(ellagic acid) 
S. N. Parameters Data of ellagic acid 
1 Retention Factor (Rf) 0.90 
2 Beer’s law limit (ng/spot) 100-600 
3 Correlation coefficients (r
2
) 0.996 
4 LOD (ng/spot) 71.85 
5 LOQ (ng/spot) 222.735 
6 
Precision (% RSD) 
Repeatability 
Intraday 
Interday 
 
0.325 
0.032 
0.024 
7 
Recovery Studies 
Accuracy (% RSD) 
SE 
Recovery % 
 
0.285 
0.236 
99.34 
8 Robustness Robust 
9 Specificity Specific 
(Mean value, n=6) 
Robustness  
The proposed method was found to be robust (Table 2).  
Recovery 
The recovery studies were done and determined by the 
standard addition technique. The %RSD was found to be 
0.285. 
Estimation of ellagic acid in crude drug and 
formulations 
The sample of selected components of GT (Terminalia 
arjuna), laboratory batches (GT-I, GT-II, GT-III) & 
marketed preparation (GTM) were prepared separately 
by weigh  sample  accurately  200 mg  and extracted in  
methanol by heating and make up 100 ml volume with 
methanol. The appropriate aliquots from prepared above 
samples extract were withdrawn in 10 ml volumetric 
flask separately. The sample solution was spotted on 
TLC plate & after that development & scanning of TLC 
plate. A single spot at Rf = 0.90 was observed in the 
sample chromatogram of the ellagic acid with some 
other components. No interference was found in analysis 
from the some other components present in the samples. 
The result of ellagic acid content was illustrated in table 3.  
 
Table 4: Content of ellagic acid in crude drug and formulations 
S. No. Name 
Ellagic acid content 
(% w/w) 
Standard error 
1 Terminalia arjuna 1.110 ± 0.135 0.104 
2 Glucomap 
GT-I 0.0255±0.134 0.116 
GT-II 0.0280±0.451 0.151 
GT-III 0.0310±0.362 0.120 
GTM 0.0220±0.235 0.148 
Mean ± SD of 6 determinations 
 
CONCLUSION:  
The developed HPTLC technique is precise, accurate, 
and robust for the determination of ellagic acid in 
Glucomap tablet. Statistical analysis proves that the 
method is reproducible for the analysis of ellagic acid. 
The content of ellagic acid in marketed polyherbal 
formulation is comparable to laboratory formulations. 
Therefore, this method can be successfully used for the 
routine analysis of ellagic acid for standardization and 
quality control of pharmaceutical products containing 
ellagic acid as an ingredient. 
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